The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.
Please enter a word or phrase into the search box to find relevant materials. If you want to search for a phrase, please use quotes, eg “Macmillan Cancer Support”, “Breast cancer”. If you have any questions about the web directory please contact Sue Hawkins firstname.lastname@example.org
This treatment guide has information about thalidomide, a drug used in the treatment of myeloma. It explains what it is, how it works, and how it is given, and describes the possible side-effects.
CAR T-cell therapy, is a type of targeted treatment used for certain types of high-grade (fast-growing) lymphoma. This factsheet explains what CAR T cells are, who can have them and how they are given, the benefits, and the possible side effects.
This treatment guide has information about carfilzomib, a proteasome inhibitor used in the treatment of myeloma. It describes how carfilzomib works, how it is given and the possible side effects.
Pomalidomide, also known as Imnovid®, is an immunomodulatory drug used in the treatment of myeloma. This treatment guide describes how it works, how it is given and the possible side effects.
Roy Castle Lung Cancer Foundation
If you or someone you care for has lung cancer, and targeted therapy is a possible treatment, then it’s almost certain that you will have a lot of questions. We have produced this booklet in partnership with lung cancer experts and people affected by lung cancer to help you make positive, informed choices about your care and treatment.
Bortezomib, also known as Velcade®, is a proteasome inhibitor drug used in the treatment of myeloma. This factsheet describes what it is, how it works, how it is given, and possible side-effects.
Breast Cancer Care
This booklet explains what pertuzumab is, when it’s given and its possible side effects. Pertuzumab is the generic (non-branded) name of the drug. Its current brand name is Perjeta®.
Steroids are often part of treatment for Hodgkin and non-Hodgkin lymphoma, including cutaneous (skin) lymphoma. This factsheet explains what steroids are, when and how they might be given, possible side effects, and the precautions that people should take when they are on steroids.
Daratumumab, also known as Darzalex®, is a monoclonal antibody drug used in the treatment of myeloma. This booklet describes what it is, how it works, how it is given, and the possible side-effects.
Isatuximab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, and its availability in the UK.